DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
نویسنده
چکیده
The Food and Drug Administration (FDA, the Agency, or we) is issuing this final rule establishing that certain active ingredients used in nonprescription (also known as overthe-counter or OTC) antiseptic products intended for use by health care professionals in a hospital setting or other health care situations outside the hospital are not generally recognized as safe and effective (GRAS/GRAE). FDA is issuing this final rule after considering the recommendations of the Nonprescription Drugs Advisory Committee (NDAC); public comments on the Agency’s notices of proposed rulemaking; and all data and information on OTC health care antiseptic products that have come to the Agency’s attention. This final rule finalizes the 1994 tentative final monograph (TFM) for OTC health care antiseptic drug products that published in the Federal Register of June 17, 1994 (the 1994 TFM) as amended by the proposed rule published in the Federal Register (FR) of May 1, 2015 (2015 Health Care Antiseptic Proposed Rule (PR)).
منابع مشابه
Medication Errors Associated With Adverse Drug Reactions in Iran (2015-2017): A P-Method Approach
Medication errors are the second most common cause of adverse patient safety incidents and the single most common preventable cause of adverse events in medical practice. Given the high human fatalities and financial burden of medication errors for healthcare systems worldwide, reducing their occurrence is a global priority. Therefore, appropriate policies to reduce medication errors, using nat...
متن کاملMemorandum Department Ofhealth and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research
متن کامل
DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION [Docket No. 75F-03551 ASPARTAME DECISION OF THE PUBLIC BOARD OF INQUIRY
متن کامل
THE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES ( FOOD AND DRUG ADMINISTRATION Dietary Supplements Containing > Ephedrine Alkaloids; Reopening
متن کامل
MEMORANDUM DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration
Please find here attached the draft Clinical Pharmacology/Biopharmaceutics Review of NDA 22,527.
متن کاملLessons learned from independent central review.
Independent central review (ICR) is advocated by regulatory authorities as a means of independent verification of clinical trial end-points dependent on medical imaging, when the data from the trials may be submitted for licensing applications [Food and Drug Administration. United States food and drug administration guidance for industry: clinical trial endpoints for the approval of cancer drug...
متن کامل